Abu Dhabi’s G42, Amazon Web Services to Launch Global Biobanking Service

The healthcare arm of Abu Dhabi-based tech company G42 has partnered with Amazon Web Services to launch new global genomics, proteomics, and biobanking service.

The deal allows G42 Healthcare to offer its sequencing, proteomics (large-scale study of proteins), and data analytics capabilities “to governments, population genome programs, and life science initiatives across the world".

The Abu Dhabi firm owns the region’s largest omics centre in the UAE capital that can deliver over 500,000 whole-genome sequences per year, which allows it to claim it has extensive experience in the field.

The term "omics" refers to a broad range of biological studies. It is typically related to using large-scale data to understand human life.

The cooperation between G42 Healthcare and AWS is an exciting milestone to provide on-demand service for multi-omics data globally. Governments and researchers can benefit from democratized access to next-generation sequencing, proteomics, and data analytics, supported by the most flexible and secure cloud computing environment available today,

said Jens Dommel, the Middle East of the AWS’ public health sector unit.